We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-17.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$47.7B
AUM Growth
-$12.1B
Cap. Flow
+$1.21B
Cap. Flow %
2.54%
Top 10 Hldgs %
20.23%
Holding
2,980
New
31
Increased
2,361
Reduced
322
Closed
49

Top Buys

Rank Stock Value
1
PLD icon
Prologis
PLD
+$22.7M
2
CNC icon
Centene
CNC
+$20M
3
IR icon
Ingersoll Rand
IR
+$18.4M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$16.8M
5
DLR icon
Digital Realty Trust
DLR
+$15.4M

Sector Composition

Rank Sector Weight
1 Technology 21.47%
2 Healthcare 14.79%
3 Financials 13.95%
4 Consumer Discretionary 9.78%
5 Communication Services 9.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNNE icon
1101
Cannae Holdings
CNNE
$649M
$4.37M 0.01%
130,355
+18,055
+16% +$670K
LMNX
1102
DELISTED
Luminex Corp
LMNX
$4.36M 0.01%
158,411
+7,715
+5% +$189K
LYFT icon
1103
Lyft
LYFT
$6.63B
$4.36M 0.01%
162,257
+25,216
+18% +$1M
FLOW
1104
DELISTED
SPX FLOW, Inc.
FLOW
$4.35M 0.01%
153,198
+8,359
+6% +$319K
CIT
1105
DELISTED
CIT Group Inc.
CIT
$4.35M 0.01%
252,165
+170,963
+211% +$6.45M
FIX icon
1106
Comfort Systems
FIX
$59.6B
$4.35M 0.01%
118,993
+1,710
+1% +$75.8K
KFY icon
1107
Korn Ferry
KFY
$4.28B
$4.35M 0.01%
178,762
+265
+0.1% +$9.77K
PSMT icon
1108
Pricesmart
PSMT
$5.46B
$4.35M 0.01%
82,719
+4,820
+6% +$282K
GBT
1109
DELISTED
Global Blood Therapeutics, Inc.
GBT
$4.35M 0.01%
85,087
+2,743
+3% +$184K
LPLA icon
1110
LPL Financial
LPLA
$28.6B
$4.34M 0.01%
79,834
-1,758
-2% -$142K
NVRO
1111
DELISTED
NEVRO CORP.
NVRO
$4.34M 0.01%
43,457
+570
+1% +$68.6K
ZWS icon
1112
Zurn Elkay Water Solutions
ZWS
$8.53B
$4.32M 0.01%
395,432
+29,313
+8% +$428K
NCLH icon
1113
Norwegian Cruise Line
NCLH
$8.84B
$4.31M 0.01%
393,245
+23,928
+6% +$962K
PCG icon
1114
PG&E
PCG
$38.5B
$4.31M 0.01%
479,357
+48,546
+11% +$645K
AYX
1115
DELISTED
Alteryx Inc
AYX
$4.31M 0.01%
45,272
+842
+2% +$105K
CNK icon
1116
Cinemark Holdings
CNK
$4.32B
$4.31M 0.01%
422,580
-586
-0.1% -$15K
TDS icon
1117
Telephone and Data Systems
TDS
$3.75B
$4.3M 0.01%
256,740
+22,245
+9% +$483K
BANR icon
1118
Banner Corp
BANR
$2.4B
$4.29M 0.01%
129,776
+5,299
+4% +$251K
STBA icon
1119
S&T Bancorp
STBA
$1.79B
$4.29M 0.01%
156,870
+9,852
+7% +$344K
NWBI icon
1120
Northwest Bancshares
NWBI
$2.28B
$4.28M 0.01%
370,073
+18,305
+5% +$267K
ACHC icon
1121
Acadia Healthcare
ACHC
$2.94B
$4.28M 0.01%
233,292
+20,953
+10% +$600K
WLY icon
1122
John Wiley & Sons Class A
WLY
$2.66B
$4.28M 0.01%
114,085
+10,401
+10% +$436K
DLB icon
1123
Dolby
DLB
$5.79B
$4.28M 0.01%
78,887
+23,650
+43% +$1.55M
SABR icon
1124
Sabre
SABR
$835M
$4.27M 0.01%
720,028
+44,590
+7% +$746K
ENPH icon
1125
Enphase Energy
ENPH
$5.53B
$4.26M 0.01%
131,944
+1,001
+0.8% +$37.7K

Similar funds

RhumbLine Advisers's Q1 2020 Portfolio in Review

As of Q1 2020, RhumbLine Advisers held 2,980 positions worth $47.7B, down 20% from $59.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trading was light in Q1 2020: portfolio turnover was 2.7%. RhumbLine Advisers opened 31 new positions and exited 49, leaving the 2,980-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q1 2020 buy was PPD, Inc. Common Stock: 58,466 shares worth $1.04M.
  • RhumbLine Advisers added most to Prologis in Q1 2020, an estimated $22.7M increase.
  • RhumbLine Advisers's biggest Q1 2020 reduction was Apple, cutting an estimated $70.6M.
  • RhumbLine Advisers fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $34.9M.
  • RhumbLine Advisers's ten largest holdings make up 20% of its $47.7B portfolio in Q1 2020.
  • RhumbLine Advisers opened 31 new positions and closed 49 in Q1 2020.
  • RhumbLine Advisers's portfolio value fell 20% quarter-over-quarter to $47.7B.

Based on RhumbLine Advisers's 13F filing for Q1 2020, filed 6 May 2020.